The growth of Microtome market is majorly driven by rising prevalence of cancer, growing demand for digital pathology, recommendations for cancer screening, availability of reimbursement. However, Lack of skilled professionals, and availability of refurbished products are some of the challenges for which may hinder the growth of Microtome market.
The global Microtome Market
is expected to reach USD 585 million by 2027 from USD 425
million in 2022, at a CAGR of 6.6% during the forecast period.
Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=230495411
Market
Segmentation:
Based on the product, the microtome market is
segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes,
Vibrating Microtomes, Other Microtomes, and Microtome Accessories. The
microtome instruments segment is expected to dominate the microtome market.
High expenditure on microtome instruments and their essential use in the
histological diagnosis of various diseases are the key factors driving the
growth of the automated microtome market.
Regional
Analysis:
Based on the North America region, the microtome
market is devided into US and cananda. US is expected to dominate the microtome
market. The high prevalence of cancer, coupled with the increasing demand for the
early and effective diagnosis and treatment of cancer, is the key factor
driving market growth in the US.
Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=230495411
Top Key Players:
The major players in the microtome market are
Danaher Corporation (US), PHC holdings corporation (Japan), Cardinal Health
(US), Boeckeler Instruments, Inc (US), SM Scientific Instruments Pvt. Ltd.
(India), Bright Instruments (UK), Sakura Finetek USA, Inc (US), Jinhua Yidi
Medical Equipment Co., Ltd (China), Ted Pella, Inc (US), Medimeas (India), SLEE
medical GmbH (Germany), Histo-Line Laboratories (Italy), microTec Laborgeräte
GmbH (Germany), MEDITE Medical GmbH (Germany), Erma Inc. (Japan)
No comments:
Post a Comment